Insurers Exploit Generic Drugs, Charging Exorbitant Prices

Insurers are charging exorbitant prices for generic drugs, which are supposed to be affordable alternatives to brand-name medications. This practice has led to increased healthcare costs for patients, as they are forced to pay thousands of dollars for drugs that should be inexpensive. The high prices are attributed to a complex system of rebates and discounts negotiated between insurers and drug manufacturers, resulting in a lack of transparency and affordability in the generic drug market.